(EGDT) (8) , corticosteroids (9) , recombinant human activated protein C (rhAPC) (10) , and lung-protective strategies (11) have all been shown to be associated with survival benefits. These and other therapeutic advances led to the development of the Surviving Sepsis Campaign (SSC) management guidelines (12) . For the early management of severe sepsis in particular, the SSC and the Institute for Healthcare Improvement recommend implementation of a 6-hr resuscitation bundle (13) , especially in the ED, that incorporates early recognition, early antibiotics, and EGDT.
Although guidelines provide a roadmap for patient care, their success relies on consistent patterns of clinician practice in order to realize the most optimal outcome. The purpose of this study was to examine the incremental impact of implementing a sepsis management initiative in the ED while integrating quality indicators via a "bundling" approach. Monitoring compliance to the quality indicators serves as a mechanism for clinician feedback and culture change that are needed to achieve uniformity in the process of care. We hoped to show that implementation of a severe sepsis bundle using quality indicators specific to the ED setting can be accomplished and that compliance to the quality indicators can result in improved patient outcomes.
METHODS AND MATERIALS

Design and Setting
This was a prospective observational cohort study of patients presenting to the ED meeting criteria for severe sepsis or septic shock and entered in a sepsis registry from October 1, 2003 , to September 30, 2005 , at an academic tertiary care medical center. The study and sepsis registry were approved by the Institutional Review Board. The ED consists of 47 beds, with approximately 65,000 annual patient visits and 2,490 intensive care unit (ICU) admissions. An additional 30,000 annual visits are seen in an on-campus urgent care department. Staffing in the adult section of the ED at any time includes two attending physicians, two to four resident physicians, and eight to ten nurses. Nurse-to-patient ratio ranges from 2:1 to 1:4, depending on the acuity of patient care. In designing this study, we a priori implemented an ED quality improvement program to deliver a severe sepsis bundle with the existing ED resources.
Creation of Sepsis Bundle and Quality Indicators
The bundle and quality indicators were derived from best practice advances in the early management of severe sepsis and septic shock (8, 9, 14, 15) . Additionally, the quality indicators were required to adhere to the following criteria: a) The indicators or interventions are generally accepted clinical practice and supported by evidence; b) the indicators need to be completed in the ED setting; c) the completion of each indicator can be determined by a yes or no on chart review; and d) the completion of the entire bundle can be determined by a yes or no. We identified five quality indicators to comprise the bundle (Table 1) . The ED Quality Improvement Committee was asked to approve the bundle before its implementation. A survey questionnaire regarding the validity (evidence-based) and feasibility (practicality) of each quality indicator was given to 23 ED physicians. A score of 1-3 (not acceptable), 4 -6 (uncertain), or 7-9 (acceptable) was assigned by each physician to rate the validity and feasibility of the quality indicators: a) initiate central venous pressure (CVP)/central venous oxygen saturation (ScvO 2 ) monitoring within 2 hrs; b) give broad-spectrum antibiotics within 4 hrs; c) complete EGDT at 6 hrs; d) give corticosteroid if the patient is on vasopressor or if adrenal insufficiency is suspected; and e) monitor for lactate clearance. The mean validity score for each quality indicator was 7.5, 8.6, 8.0, 7.3, 7.4 , and the mean feasibility score was 6.7, 8.5, 6.4, 7.3, 5.9, respectively.
Bundle Implementation and Quality Improvement Process
The 2-yr implementation program was divided into 3-month quartiles that included baseline, education, and operational, followed by five quality improvement (QI) phases. The baseline phase included data gathering on the current level of care applying a standardized checklist. This checklist was used to gather bundle compliance data (see Data Collection section). Equipment for CVP and ScvO 2 monitoring was also acquired during the baseline phase. The education phase consisted of physician, nurse, and residency staff training on sepsis definitions and recognition, hemodynamic monitoring using CVP and ScvO 2 , EGDT, bundle initiation criteria, and bundle quality indicators. A physician champion and nurse educator provided conference lectures, bedside teaching, and in-services to physicians and nurses during this phase. The operational phase consisted of bundle delivery in the ED setting. Physicians and nurses used a sepsis toolkit (16) and pocket cards as daily reminders of the processes involved in bundle delivery. This phase was considered a trial period without accountability by the physicians and nurses. The QI phase consisted of five quartiles (QI 1 to QI 5). Physician and nursing feedback at the end of each QI quartile was used to increase bundle compliance. An interval summary report was distributed to physicians and nurse managers that included the number of severe sepsis patients who met indications for the bundle, treatments given in the ED, percentage compliance with bundle quality indicators, and outcome. Individual cases were discussed in a peer-review forum, and a reminder letter from the ED medical director was sent to physicians who did not complete the bundle in patients for whom there were indications.
Patient Management
Once a patient met bundle initiation criteria, hemodynamic monitoring was initiated with placement of a central venous catheter for CVP and with the internal jugular or subclavian vein approach for ScvO 2 monitoring. After radiographic verification of catheter placement, the ED nurse then performed calibration for CVP and ScvO 2 monitoring. Broadspectrum antibiotics were administered. Hemodynamic optimization following the EGDT protocol (8) targeting CVP Ն8 mm Hg, systolic blood pressure Ն90 mm Hg or mean arterial pressure Ն65 mm Hg, and ScvO 2 Ն70% was achieved using fluid resuscitation, red blood cell transfusion, vasopressors, and inotropes at the treating physician's discretion. Mechanical ventilation was initiated if necessary. Corticosteroid was administered if the patient became vasopressor-dependent or if adrenal insufficiency was suspected. A repeat lactate level was obtained to assess for lactate clearance (15) . The bundle was delivered by ED physicians, residents, and nurses as standard care. No additional staffing resources were acquired. All patients were admitted to the ICU. Intensive care consultation was obtained for ICU admission; however, the intensivists were not involved in the delivery of the bundle in the ED before admission. Since the goal of the quality improvement program was completion Percentage compliance during an implementation phase (i.e., a 3-month period) was defined as the number of patients completing the particular bundle quality indicator (or the numerator) divided by the number of patients meeting the criteria for initiation of the bundle (or the denominator).
of bundle quality indicators in the ED, we did not develop a transfer of care protocol to the intensive care setting. However, the intensivists continued the management of severe sepsis and septic shock in the ICU as recommended by established guidelines (12, 17) .
Data Collection and Sepsis Registry
Patient Selection. A monthly review of patient medical charts was performed to enroll patients. A two-level screening process was used to select patients meeting criteria for initiation of the bundle (Table 2) . Level 1 screening included a monthly list of patients from medical records meeting the following criteria: a) admission to the hospital from the ED; and b) sepsisrelated International Classification of Diseases, Ninth Revision diagnosis. Level 2 screening consisted of review of medical charts obtained from level 1 screening. Patients meeting criteria for initiation of the bundle were included in the bundle compliance measurement process and entered into a sepsis registry. Patients with age Ͻ18, trauma, seizure, pulmonary edema due to acute heart failure, stroke, active hemorrhage, or do-not-resuscitate orders were excluded during level 2 screening from the compliance measurement process and the sepsis registry.
Bundle Compliance Measurement. Trained data abstractors completed a bundle compliance checklist for each patient selected after level 2 screening. The physician champion for the bundle implementation then verified the compliance checklist for correctness. Data obtained included patient demographics, date and time of arrival in the ED, time meeting criteria for initiation of the bundle, sepsis category, completion (yes or no) and time of completion of the bundle quality indicators, completion of the whole bundle, ED length of stay, hospital length of stay, and in-hospital mortality. Other data such as vital signs, laboratories, physiologic scores, therapies in the ED, and therapies up to 72 hrs in the ICU were also obtained. The physiologic scores were computed from available data and included Acute Physiology and Chronic Health Evaluation II (18) , Mortality in Emergency Department Sepsis (19) , Simplified Acute Physiology Score II (20) , and Mortality Prediction Model II 0 at admission (21) .
Timing of Bundle (Time Zero).
The time from ED arrival that a patient met criteria for initiation of the bundle and the time a physician was accountable for applying the quality indicators of the bundle was defined as time zero. As each chart was reviewed during level 2 screening, time zero was the time systolic blood pressure remained Ͻ90 mm Hg after a 20-mL/kg fluid bolus, or the time a lactate result was available and Ն4 mmol/L in a patient with systemic inflammatory response syndrome (22) and a chart notation by the physician suspecting a source of infection (Table 2) .
Statistical Analysis
The Statistical Analysis System software (SAS Institute, Cary, NC) was used to perform data analysis. Patients enrolled in the sepsis registry after meeting level 2 screening were analyzed. The sepsis registry was maintained in an Access database (Microsoft, Redmond, WA). Chisquare, Fisher's exact test, and unpaired Student's t-test were used when appropriate in testing for differences between groups. The outcome measurements included bundle percentage compliance, hospital length of stay, and inhospital mortality. Univariate and multivariate logistic regression models were performed, with mortality as the dependent variable and individual bundle quality indicators as independent variables. Statistical significance was defined as p Ͻ .05. Data are presented as mean Ϯ SD. Proportions are presented as percentage and raw data. Patients with missing values were excluded from calculations of means and percentages.
RESULTS
There were 1,217 patients meeting level 1 screening criteria during the study period, with 330 patients meeting level 2 screening criteria and entered into the sepsis registry. The mean age was 63.8 Ϯ 18.5, with Acute Physiology and Chronic Health Evaluation II score 29.6 Ϯ 10.6, ED length of stay 8.5 Ϯ 4.4 hrs, hospital length of stay 11.3 Ϯ 12.9 days, and inhospital mortality 35.2%.
Comparison of Bundle Implementation Phases and Compliance
Patient characteristics were similar throughout the bundle implementation phases (Table 3) . Bundle compliance showed a progressive improvement from the baseline phase, at zero percentage compliance, to the end of QI 5 phase, at 51.2% compliance (Fig. 1) .
Comparison of Bundle Completed With Bundle Not Completed
There was no difference in patient characteristics between those with the bundle completed compared with patients with the bundle not completed (or only received some of the bundle quality indicators), except that patients with the bundle completed had lower lactate (3.3 Ϯ 2.4 vs. 4.3 Ϯ 3.6 mmol/L, p ϭ .03) and higher ScvO 2 (70.1 Ϯ 11.6 vs. 63.3 Ϯ 18.4%, p Յ .01) than those with the bundle not completed (Table 4) . Patients with the bundle completed had higher percentage compliance of all quality indicators compared with patients with the bundle not completed (all p Ͻ .01). During the ED stay, patients with the bundle completed received more CVP/ ScvO 2 monitoring (100.0 vs. 64.8%, p Ͻ .01), more antibiotics (100.0 vs. 89.7%, p ϭ .04), and more corticosteroid (29.9 vs. 16.2%, p ϭ .01). There was no difference in ED length of stay and hospital length of stay between patients with the bundle completed compared with patients with the bundle not completed. In-hospital mortality was less in patients with the bundle completed compared with patients with the bundle not completed (20.8 vs. 39.5%, p Ͻ .01). 
Completion of Bundle Quality Indicators and Associated Mortality Benefit
Univariate comparisons of mortality in patients receiving the individual bundle quality indicators and those patients not receiving the indicators were performed (Fig. 2) 
DISCUSSION
The application of evidence-based guidelines to the patient bedside is often difficult. Recently, a few studies have shown the feasibility of providing the level of care recommended by the SSC guidelines for severe sepsis patients, with suggested outcome benefits in small samples of patients (23) (24) (25) (26) (27) . The limitation remains a comprehensive implementation of the sepsis bundle in the ED setting. Our study suggests that a severe sepsis bundle can be implemented as standard care among ED physicians and nurses at our institution through the use of compliance measurements and feedback. Our quality improvement effort included the largest single-center cohort of patients and required 2 yrs to achieve Ͼ50% completion of the bundle, with 82.9% of patients having the bundle initiated (i.e., receiving CVP/ScvO 2 monitoring) at the end of the study period. Although we had hoped to achieve Ͼ80% completion of the bundle by the end of the study period, our results are similar to those shown by Gao et al (26) . They prospectively observed the compliance of a modified SSC 6-hr sepsis bundle at two hospitals in the UK, using hemoglobin target 7-9 g/dL and hypotension after fluid resuscitation instead of ScvO 2 as a threshold for initiating inotrope therapy. They noted a 52% compliance with the 6-hr sepsis bundle and a 26% absolute decrease in mortality. Using a more stringent bundle and quality indicators, requiring CVP and ScvO 2 monitoring, our current compliance is also relatively higher than with other therapies for severe sepsis. Lung-protective strategies have been achieved only in 39% of patients on day 2 of acute lung injury (28) . Tight glucose control was achieved in 19% of the time with routine insulin protocols (29) . The administration of rhAPC ranged from 4% to 33% of patients in other studies (14.3% in patients with bundle completed in this study) examining the effectiveness of a sepsis protocol (23) (24) (25) .
The bundle is unique in that it is applicable during the earliest hours of severe sepsis presentation. The items of the bundle are treatment goals that can be abstracted from the medical chart with a yes or no answer for completion. The items themselves are inherent quality indicators with supporting evidence associated with improved outcome: early antibiotics (14) , EGDT (8) , appropriate corticosteroid (9), and lactate clearance (15) . Most important, the bundle quality indicators were accepted by the implementing physicians as valid and feasible a priori bundle implementation.
Although the implementation of the bundle was an ED-based process of care improvement initiative targeting the quality indicators, and not a controlled clinical trial, our study showed a few interesting results. First, time zero or the time from ED arrival to meeting criteria for severe sepsis (lactate Ն4 mmol/L) or septic shock (refractory hypotension) ranged from immediate to 17.0 hrs. This observation supports the concept of "cryptic shock." Septic patients with significant systemic hypoperfusion may initially present with normal or high blood pressure in the ED and may require a few hours before the fluid refractory hypotension (vasodilation) occurs. In the original EGDT study, 18% of enrolled patients had mean arterial pressure Ͼ100 mm Hg, and 14% of these later died from sudden cardiovascular collapse or vasodilatory shock in the ICU (8, 30) .
Second, patients with the bundle completed had a lower lactate and higher ScvO 2 compared with the patients with the bundle not completed. Perhaps these patients met their hemodynamic goals with an associated lower mortality because they had less disease severity. However, both groups had similar percentages of patients with septic shock, suggesting that most patients received the bundle based on hypotension refractory to fluids rather than lactate criterion. Physiologic scores, culture results, and other laboratories were similar between patients with the bundle completed and patients with bundle not completed. After adjustment for unequal lactate and ScvO 2 , patients with the bundle completed still had decreased odds ratio for mortality.
Third, the patients with the bundle completed had no difference in fluids, transfusion, vasopressor, or inotrope administration compared with patients with the bundle not completed. These results were different from the original EGDT study, where more fluids, transfusion, and inotrope were administered, with less vasopressor usage in the treatment group. Perhaps the physicians in clinical practice tended to use more vasopressor than fluids to achieve the hemodynamic goals compared with the researchers in the original EGDT study who used more fluids, transfusion, and inotrope. Furthermore, mean CVP was consistently Ͼ8 mm Hg throughout the study period, suggesting that patients in this study were not as hypovolemic and required less fluid resuscitation compared with patients in the original EGDT study. Regardless, the primary aim of the bundle was for clinicians to achieve the quality indicators rather than target a specific resuscitation strategy. Although we do not claim that EGDT compliance was the limiting factor in decreased mortality, we surmise that EGDT completion may be the most important quality indicator associated with improved outcome when examined in a multivariate analysis including the other bundle quality indicators.
Finally, although rhAPC administration was not a quality indicator in the bundle, patients with the bundle completed received more rhAPC compared with patients with the bundle not completed. Thus, patients who had the bundle completed tended to be evaluated for and to receive rhAPC. This phenomenon may have resulted from variability in clinical practice among physicians completing the bundle compared with those physicians not completing the bundle.
Limitations
Our study was nonrandomized; therefore, the implementation of the bundle and quality indicators were at best associated with a mortality benefit and not causal. However, given the quality improvement initiatives advocating the implementation of severe sepsis bundles, we were limited by the ethical constraints of performing a randomized trial examining the utility of the bundle (or standard care).
Our use of corticosteroid as a quality indicator and its association with a decreased odds ratio for mortality should be interpreted with caution. We adopted the SSC guidelines recommendation that in a patient requiring vasopressor therapy after fluid resuscitation, corticosteroid should be started without waiting for the adrenocorticotropic hormone stimulation result (12) . Thus, we do not know how many patients receiving corticosteroid in our study actually have relative adrenal insufficiency and are the patients with the most benefit from corticosteroid administration (9, 31) . However, one study showed that 19% of hemodynamically unstable vasopressor-dependent patients in the ED have relative adrenal insufficiency (32).
We did not measure the variables involved in process improvement. What were the barriers in bundle compliance? How do we know individual physicians changed their behaviors? How effective was physician feedback in improving compliance? What role does administrative leadership play in effecting compliance (33, 34)? Although we did not explicitly study these factors, we observed that completion of the EGDT hemodynamic goals was the limiting factor in achieving compliance. In a busy ED with the ED physician continually multitasking, it is difficult to initiate vasopressor, inotrope, and transfusion in a timely way to meet the CVP, mean arterial pressure, and ScvO 2 goals at 6 hrs. Other factors may include simple lack of documentation. As compliance was measured by chart review, an optimal but undocumented CVP at 6 hrs would equate to noncompliance to the bundle. These process barriers may be inherent to our attempt at a culture change in the standard care. Perhaps a "shock team" approach with a physician at bedside (35) and concurrent measurement of compliance during the bundle completion would have further increased our compliance. However, we believe that physician education, physician buy-in as shown by our initial survey on the bundle validity and feasibility, and regular physician and nursing feedback were as important.
CONCLUSIONS
We showed that a severe sepsis bundle could be feasibly implemented in the ED setting by an ED-centralized model with no additional staffing resources. Clinician feedback was crucial in achieving compliance, and successful completion of the bundle quality indicators may be associated with improved outcome. As a result of this effort, we have increased our awareness of severe sepsis and the importance of early recognition and intervention even though the patient may appear stable. With unavoidable prolonged ED length of stays, the physicians and nurses were committed to providing the level of intensive care required by the bundle to avoid the potential cardiovascular demise that may occur before ICU bed availability.
Although other institutions are implementing similar quality improvement programs with the use of the sepsis bundles and sharing their results, we pose a few questions for future studies. Can bundle implementation be generalized in most institutions, such as community vs. academic tertiary care centers? Are these quality indicators applicable in other ED settings, on the medical ward, or in the ICU? What component of the bundle is most effective, or will a partial bundle be just as effective as a complete bundle? What efforts and time are needed to increase bundle completion to Ͼ95%? What resource limitations prevent bundle compliance? What strategies are most effective in overcoming implementation barriers? What implementation model is best (ED centralized, ICU centralized, or a multidisciplinary team model)? While we and others await answers to these questions, we have already begun the process of providing better care for patients with severe sepsis or septic shock.
